Ausgabe 2/2009
Inhalt (17 Artikel)
Recent advances in systemic therapy. Advances in adjuvant systemic chemotherapy of early breast cancer
Sara López-Tarruella, Miguel Martín
Recent advances in systemic therapy. Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents
Michael Untch, Gunter von Minckwitz
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Achim Rody, Uwe Holtrich, Laos Pusztai, Cornelia Liedtke, Regine Gaetje, Eugen Ruckhaeberle, Christine Solbach, Lars Hanker, Andre Ahr, Dirk Metzler, Knut Engels, Thomas Karn, Manfred Kaufmann
Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer
Pepper Schedin, Virginia Borges
The breast cancer somatic 'muta-ome': tackling the complexity
Andrew E Teschendorff, Carlos Caldas
Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer
Catherine Oakman, Silvia Bessi, Elena Zafarana, Francesca Galardi, Laura Biganzoli, Angelo Di Leo
FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors
Alma Carracedo, Kristof Egervari, Marta Salido, Federico Rojo, Josep M Corominas, Montserrat Arumi, Cristina Corzo, Ignacio Tusquets, Blanca Espinet, Ana Rovira, Joan Albanell, Zoltan Szollosi, Sergi Serrano, Francesc Solé
Peroxisome proliferator-activated receptor-γ protects ERBB2-positive breast cancer cells from palmitate toxicity
Antonis Kourtidis, Rekha Srinivasaiah, Richard D Carkner, M Julia Brosnan, Douglas S Conklin
TLE3 as a candidate biomarker of response to taxane therapy
Swati A Kulkarni, David G Hicks, Nancy L Watroba, Christine Murekeyisoni, Helena Hwang, Thaer Khoury, Rodney A Beck, Brian Z Ring, Noel C Estopinal, Marshall T Schreeder, Robert S Seitz, Douglas T Ross
Triple-negative breast cancers are increased in black women regardless of age or body mass index
Lesley A Stead, Timothy L Lash, Jerome E Sobieraj, Dorcas D Chi, Jennifer L Westrup, Marjory Charlot, Rita A Blanchard, John C Lee, Thomas C King, Carol L Rosenberg
Number crunching in the cancer stem cell market
Malcolm R Alison, Shahriar Islam, Susan ML Lim
Loss of TGF-β or Wnt5a results in an increase in Wnt/β-catenin activity and redirects mammary tumour phenotype
Kevin Roarty, Sarah E Baxley, Michael R Crowley, Andra R Frost, Rosa Serra
Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells
Kara L Britt, Howard Kendrick, Joseph L Regan, Gemma Molyneux, Fiona-Ann Magnay, Alan Ashworth, Matthew J Smalley
Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis
Johanna R Reed, Ronald P Leon, Majken K Hall, Kathryn L Schwertfeger
The multiplex bead array approach to identifying serum biomarkers associated with breast cancer
Byoung Kwon Kim, Jong Won Lee, Pil Je Park, Yong Sung Shin, Won Young Lee, Kyung Ae Lee, Sena Ye, Heesun Hyun, Kyung Nam Kang, Donghwa Yeo, Youngdai Kim, Sung Yup Ohn, Dong Young Noh, Chul Woo Kim
Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer
Jocelyne Jacquemier, Emmanuelle Charafe-Jauffret, Florence Monville, Benjamin Esterni, Jean Marc Extra, Gilles Houvenaeghel, Luc Xerri, François Bertucci, Daniel Birnbaum
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms
Rachael A Hancox, Michael D Allen, Deborah L Holliday, Dylan R Edwards, Caroline J Pennington, David S Guttery, Jacqueline A Shaw, Rosemary A Walker, J Howard Pringle, J Louise Jones